Ars Investment Partners, LLC Red Hill Biopharma Ltd. Transaction History

Ars Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.31 - $5.85 $121,263 - $307,095	-52,495 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$4.55 - $10.36 $172,162 - $392,001	-37,838 Reduced 41.89%	52,495 $240,000
Q2 2021 Aug 06, 2021	BUY	$5.98 - $7.51 $14,926 - $18,744	2,496 Added 2.84%	90,333 $621,000
Q1 2021 May 13, 2021	BUY	$6.98 - $11.29 $70,658 - $114,288	10,123 Added 13.03%	87,837 $643,000
Q4 2020 Feb 09, 2021	BUY	$7.81 - $10.39 $148,780 - $197,929	19,050 Added 32.47%	77,714 $628,000
Q3 2020 Nov 12, 2020	BUY	$6.34 - $10.83 $371,929 - $635,331	58,664 New	58,664 $600,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ars Investment Partners, LLC with notifications on news.